9 diciembre 2014
The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live ≥50 miles away from a cancer center, according to a study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/vUysjBo0By0/141209115809.htm
